High quality N-(4-ethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide CAS:4711-68-6 99%min CAS NO.4711-68-6

Our company  was established in 2007. It is a high-tech pharmaceutical chemical company integrating R&D, production and sales.Has a first-class R & D team, rich experience in custom compound synthesis, good at synthesis of organic compounds such as chiral, heterocyclic, benzene rings,Our company has won the trust of customers at home and abroad with competitive price, high quality products, quick response, high quality sales service, steady and honest style, and the concept of providing one-stop service for customers. and support,We have refined line design and route optimization and are committed to providing timely and efficient customization services. At the same time, we are experienced in multi-step synthesis, heterocyclic compounds, chiral compounds, sugar compounds,Have an excellent management team and a group of high-quality R & D personnel and experienced technical staff,It is a high-tech enterprise integrating R&D, production and sales of APIs, pharmaceutical intermediates, fine chemicals and special catalysts

Our company  was established in 2007. It is a high-tech pharmaceutical chemical company integrating R&D, production and sales.In the complete production service chain with gram-kg-ton class, it can realize rapid response in the product development- pilot-amplification process and quickly transform technology into production,Since the establishment of the company, it has established good and stable cooperative relations with many domestic and foreign pharmaceutical companies. The products are exported to Europe, America, Middle East, India, Southeast Asia and other countries and regions, and have been recognized and highly praised by the market and customers,Has a group of experienced researchers in the field of organic synthetic chemistry, with the ability to solve problems and troubleshoot,We offer a wide range of custom synthesis and production services for pharmaceutical intermediates, reference compounds and new reagents for pharmaceutical companies, pharmaceutical biotech companies, universities and research institutions.